Chronic Obstructive Pulmonary Disease Illness and Medication Beliefs are Associated with Medication Adherence

References

• Halpin DM, Miravitlles M. Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Amer Thor Soc 2006; 3(7):619–23.
   PubMedGoogle Scholar
• Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang XY, Giles WH. COPD Surveillance-United States, 1999–2011. Chest 2013; 144(1):284–305.
   PubMed Web of Science ®Google Scholar
• Wise RA. Changing smoking patterns and mortality from chronic obstructive pulmonary disease. Prev Med 1997; 26(4):418–421.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick P, Dransfield MT. Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr Opin Pulm Med 2009; 15(2):100–104.
   PubMed Web of Science ®Google Scholar
• Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27(1):188–207.
   PubMed Web of Science ®Google Scholar
• Niewoehner DE. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease. Am J Med 2006; 119(10 Suppl 1):38–45.
   PubMed Web of Science ®Google Scholar
• Effing T, Monninkhof EM, van der Valk PDLPM, van der Palen J, van Herwaarden CLA, Partidge MR, et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Db Syst Rev 2007; (4).
   PubMed Web of Science ®Google Scholar
• Effing T. Action plans and case manager support may hasten recovery of symptoms following an acute exacerbation in patients with chronic obstructive pulmonary disease (COPD). J Physiother 2012; 58(1):60.
   PubMed Web of Science ®Google Scholar
• Effing TW, Kerstjens HAM, van der Valk PDLPM, Zielhuis GA, van der Palen J, Ii C. The (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in COPD Patients: The COPE II-study. Am J Resp Crit Care 2009; 179.
   PubMed Web of Science ®Google Scholar
• Ferguson GT. Recommendations for the management of COPD. Chest 2000; 117(2):23–28.
   Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD Executive Summary. Am J Respir Crit Care Med 2012. Feb 15; 187(4):347–65.
   PubMed Web of Science ®Google Scholar
• Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, et al. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med 2009; 169(15):1403–1410.
   PubMed Web of Science ®Google Scholar
• Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(10):948–955.
   PubMed Web of Science ®Google Scholar
• Serra-Batlles J, Plaza V, Badiola C, Morejon E. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. J Aerosol Med 2002; 15(1):59–64.
   PubMedGoogle Scholar
• Chryssidis E, Frewin DB, Frith PA, Dawes ER. Compliance with aerosol therapy in chronic obstructive lung disease. New Zeal Med J 1981; 94(696):375–377.
   PubMed Web of Science ®Google Scholar
• Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991; 99(4):837–841.
   PubMed Web of Science ®Google Scholar
• Lee H, Boo S, Lim Y, Kim S, Kim IA. Accuracy of inhaler use in patients with chronic obstructive pulmonary disease. Clin Nurs Res 2013.
   Web of Science ®Google Scholar
• Huetsch JC, Uman JE, Udris EM, Au DH. Predictors of adherence to inhaled medications among Veterans with COPD. J Gen Intern Med 2012; 27(11):1506–12.
   PubMed Web of Science ®Google Scholar
• Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial. Br Med J 2000; 320(7245):1297–1303.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: A 2 year follow up study. Thorax 2004; 59(5):387–395.
   PubMed Web of Science ®Google Scholar
• van Boven JF, Chavannes NH, van der Molen T, Rutten-van Molken MP, Postma MJ, Vegter S. Clinical and economic impact of non-adherence in COPD: A systematic review. Respir Med 2013.
   PubMed Web of Science ®Google Scholar
• Horowitz CR, Rein SB, Leventhal H. A story of maladies, misconceptions and mishaps: effective management of heart failure. Soc Sci Med 2004; 58(3):631–643.
   PubMed Web of Science ®Google Scholar
• Horne R, Clatworthy J, Polmear A, Weinman J. Do hypertensive patients’ beliefs about their illness and treatment influence medication adherence and quality of life? J Hum Hypertens 2001; 15:S65–S68.
   PubMed Web of Science ®Google Scholar
• Mann DM, Ponieman D, Leventhal H, Halm EA. Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med. 2009; 32(3):278–284.
   PubMed Web of Science ®Google Scholar
• Brown C, Battista DR, Sereika SM, Bruehlman RD, Dunbar-Jacob J, Thase ME. Primary care patients’ personal illness models for depression: relationship to coping behavior and functional disability. Gen Hosp Psych 2007; 29(6):492–500.
   PubMed Web of Science ®Google Scholar
• Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS 2004; 15(1):38–44.
   PubMed Web of Science ®Google Scholar
• George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005; 128(5):3198–3204.
   PubMed Web of Science ®Google Scholar
• Khdour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Euro J Clin Pharmacol 2012; 68(10):1365–1373.
   PubMed Web of Science ®Google Scholar
• Cohen JL, Mann DM, Wisnivesky JP, Home R, Leventhal H, Musumeci-Szabo TJ, et al. Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the Medication Adherence Report Scale for Asthma. Ann Allergy Asthma Immunol 2009; 103(4):325–331.
   PubMed Web of Science ®Google Scholar
• Krauskopf KA, Sofianou A, Goel MS, Wolf MS, Wilson EA, Martynenko ME, et al. Depressive symptoms, low adherence, and poor asthma outcomes in the elderly. J Asthma J Asso Care Asthma 2013; 50(3):260–266.
   PubMed Web of Science ®Google Scholar
• Sofianou A, Martynenko M, Wolf MS, Wisnivesky JP, Krauskopf K, Wilson EA, et al. Asthma beliefs are associated with medication adherence in older asthmatics. J Gen Intern Med 2012. 2013 Jan; 28(1):67–73.
   PubMed Web of Science ®Google Scholar
• Wisnivesky JP, Krauskopf K, Wolf MS, Wilson EA, Sofianou A, Martynenko M, et al. The association between language proficiency and outcomes of elderly patients with asthma. Ann Allergy Asthma Immunol 2012; 109(3):179–184.
   PubMed Web of Science ®Google Scholar
• Sjˆlander M EM, Glader EL. The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey. BMJ Open 2013; 3:e003551.
   PubMed Web of Science ®Google Scholar
• Selinger CP, Eaden J, Jones DB, Katelaris P, Chapman G, McDonald C, et al. Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease. Inflamm Bowel Dis 2013; 19(10):2199–2206.
   PubMed Web of Science ®Google Scholar
• Huther J, von Wolff A, Stange D, Harter M, Baehr M, Dartsch DC, et al. Incomplete medication adherence of chronically ill patients in German primary care. Patient Prefer Adher 2013; 7:237–244.
   PubMed Web of Science ®Google Scholar
• Leventhal H BI, Leventhal E. The Common Sense Models of Self-regulation of Health and Illness. London: Taylor & Francis Books, Ltd;. 2003.
   Google Scholar
• Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006; 60(6):631–7.
   PubMed Web of Science ®Google Scholar
• The Illness Perception Questionnaire Website.
   Google Scholar
• Horne R. Patients’ beliefs about treatment: The hidden determinant of treatment outcome? J Psychosom Res 1999; 47(6):491–495.
   PubMed Web of Science ®Google Scholar
• Ponieman D, Wisnivesky JP, Leventhal H, Musumeci-Szabo TJ, Halm EA. Impact of positive and negative beliefs about inhaled corticosteroids on adherence in inner-city asthmatic patients. Ann Allergy Asthma Immunol 2009; 103(1):38–42.
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999; 14(1):1–24.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National Health Interview Survey. http://www.cdc.gov/nchs/nhis.htm.
   Google Scholar
• Eisner MD, Trupin L, Katz PP, Yelin EH, Earnest G, Balmes J, et al. Development and validation of a survey-based COPD severity score. Chest 2005; 127(6):1890–1897.
   Google Scholar
• Omachi TA, Yelin EH, Katz PP, Blanc PD, Eisner MD. The COPD severity score: a dynamic prediction tool for health-care utilization. COPD 2008; 5(6):339–346.
   PubMedGoogle Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: L. Erlbaum Associates; 1988. xxi.
   Google Scholar
• Halm EA, Mora P, Leventhal H. No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest 2006; 129(3):573–580.
   PubMed Web of Science ®Google Scholar
• Qian J, Simoni-Wastila L, Rattinger GB, Zuckerman IH, Lehmann S, Wei YJ, et al. Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease. Inter J Geriat Psych 2014; 29(1):49–57.
   PubMed Web of Science ®Google Scholar
• Turan O, Yemez B, Itil O. The effects of anxiety and depression symptoms on treatment adherence in COPD patients. Prim Health Care Res Develop 2013: 1–8.
   PubMed Web of Science ®Google Scholar
• Peytremann-Bridevaux I, Staeger P, Bridevaux PO, Ghali WA, Burnand B. Effectiveness of chronic obstructive pulmonary disease-management programs: Systematic review and meta-analysis. Am J Med 2008; 121(5):433–U125.
   PubMed Web of Science ®Google Scholar
• Bourbeau J. Preventing hospitalization for COPD exacerbations. Semin Resp Crit Care 2010; 31(3):313–320.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Revised 2011. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf.
   Google Scholar
• O’Donnell DE. DE O’Donnell, P Hernandez, A Kaplan, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J 2008; 15 (Suppl A): 1A–8A. Can Respir J. 2008; 15(4):219.
   Google Scholar